Showing results (6281-6290 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|April 12, 2002
Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approachesLaura Tarrago-Litvak, Marie Line Andreola, Michel Fournier, et al.Current Pharmaceutical Design|April 12, 2002
Cationic peptides: distribution and mechanisms of resistanceDeirdre A Devine, Robert E W HancockCurrent Pharmaceutical Design|April 12, 2002
Host-defense antimicrobial peptides: importance of structure for activityN Sitaram, R NagarajCurrent Pharmaceutical Design|April 12, 2002
Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of actionRenato Gennaro, Margherita Zanetti, Monica Benincasa, et al.Current Pharmaceutical Design|April 12, 2002
Cathelicidin peptides as candidates for a novel class of antimicrobialsMargherita Zanetti, Renato Gennaro, Barbara Skerlavaj, et al.Current Pharmaceutical Design|February 20, 2010
Bisphosphonates as treatment of bone metastasesIngunn Holen, Robert E ColemanCurrent Pharmaceutical Design|February 20, 2010
Tgf-Beta pathway as a therapeutic target in bone metastasesPatricia Juárez, Theresa A GuiseCurrent Pharmaceutical Design|February 20, 2010
Targeting RANK/RANKL in the treatment of solid tumours and myelomaC H Buckle, H L Neville-Webbe, P I Croucher, et al.Current Pharmaceutical Design|February 20, 2010
Most efficient routes for the synthesis of alpha,beta-diamino acid-derived compoundsJiang Wang, Lei Zhang, Hualiang Jiang, et al.Pageof 1,008